Hepatocellular carcinoma and type 2 diabetes mellitus: cytokeratin 8/18 expression in hepatocellular carcinoma and glycogen-storing hepatocytes

References

[1] Takegoshi K,Nomoto K,Sawasaki T,Terakawa H,Yabushita K,Terahata S.Hepatocellular carcinoma and type 2 diabetes mellitus: two cases highlighting changes in tumor glycogen content..Hepatoma Res2016;2:26-30

[2] Bannasch P,Mayer D.Early bioenergetic changes in hepatocarcinogenesis: preneoplastic phenotypes mimic responses to insulin and thyroid hormone..J Bioenerg Biomembr1997;29:303-13

[3] Strnad P,Jang KH.Keratins: markers and modulators of liver disease..Curr Opin Gastroenterol2012;28:209-16

[4] Su Q,Otto G.Cytokeratin expression is reduced in glycogenotic clear hepatocytes but increased in ground-glass cells in chronic human and woodchuck hepadnaviral infection..Hepatology1998;28:347-59

[5] Mathew J,Gilbert S,Marceau N.Keratin 8/18 regulation of glucose metabolism in normal versus cancerous hepatic cells through differential modulation of hexokinase status and insulin signaling..Exp Cell Res2013;319:474-86